US Patent Issued to ANTECIP BIOVENTURES II on Oct. 20 for "Bupropion as a modulator of drug activity" (New York Inventor)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,766,139, issued on Oct. 20, was assigned to ANTECIP BIOVENTURES II LLC (New York).

"Bupropion as a modulator of drug activity" was invented by Herriot Tabuteau (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "Dosage forms, drug delivery systems, and methods related to sustained release of dextromethorphan or improved therapeutic effects are disclosed. Typically, bupropion or a related compound is orally administered to a human being to be treated with, or being treated with, dextromethorphan."

The patent was filed on July 2, 2025, under Application No. 19/258,712.

*For further information, including images, charts and tables, please visit: htt...